Reply to Boyd et al., "Evidence that remdesivir treatment reduces viral titers in patients with COVID-19".

IF 4.1 2区医学 Q2 MICROBIOLOGY

Antimicrobial Agents and Chemotherapy Pub Date : 2024-12-05 Epub Date: 2024-11-07 DOI:10.1128/aac.01363-24

Isa Faghihi, Victoria C Yan

引用次数: 0

查看原文本刊更多论文

答复 Boyd 等人，"雷米替韦治疗可降低 COVID-19 患者病毒滴度的证据"。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Antimicrobial Agents and Chemotherapy 医学-微生物学

CiteScore

10.00

自引率

8.20%

发文量

762

审稿时长

3 months

期刊介绍： Antimicrobial Agents and Chemotherapy (AAC) features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy.